Dextenza intraocular and Japanese encephalitis virus vaccine SA14-14-2
Determining the interaction of Dextenza intraocular and Japanese encephalitis virus vaccine SA14-14-2 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: japanese enceph vacc sa14-14-2, inactivated
Brand name: Ixiaro
Synonyms: Japanese encephalitis virus vaccine (SA14-14-2), Japanese Encephalitis Virus Vaccine (Inactivated)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Jardiance
- Dextenza intraocular-Jasmiel
- Dextenza intraocular-Jatenzo
- Dextenza intraocular-Jay-Phyl
- Dextenza intraocular-Jay-Phyl Syrup
- Dextenza intraocular-Jencycla
- Japanese encephalitis virus vaccine SA14-14-2-Dextran 40
- Japanese encephalitis virus vaccine SA14-14-2-Dextran 70 6% in 5% Dextrose high molecular weight
- Japanese encephalitis virus vaccine SA14-14-2-Dextran 75
- Japanese encephalitis virus vaccine SA14-14-2-Dextran high molecular weight
- Japanese encephalitis virus vaccine SA14-14-2-Dextranomer and Hyaluronate Derivatives (Deflux)
- Japanese encephalitis virus vaccine SA14-14-2-Dextranomer and Hyaluronate Derivatives (Solesta)